The Bottom Line The legalization of hemp is a major step in establishing a potentially significant new industry. However, producers and marketers need to exercise caution when making health-related claims in connection with hemp-based product. The FTC and FDA will continue to aggressively review Continue Reading
FTC and FDA Sent Warning Letters to Companies Advertising Products that Claim Treatment of Disease
The Bottom Line The FTC and FDA are aggressively reviewing companies’ websites and social media channels for false or unsubstantiated health claims and efficacy claims. Advertisements on company websites and in social media posts must avoid false or unsubstantiated health claims, and efficacy Continue Reading
Regulatory and Class Action Claims Against “Healthy” and “Natural” Food and Dietary Supplement Products on the Rise
5th Edition: Trends in Marketing Communications Law The U.S. Food and Drug Administration (FDA) and class action bar are continuing to pursue enforcement and litigation against food and dietary supplement manufacturers who make drug claims, and in 2017, paid particular attention to products Continue Reading
FDA Withdraws Anti-Aging Import Alert and Continues Oversight Over Cosmetics Claims
5th Edition: Trends in Marketing Communications Law In late 2017, the U.S. Food and Drug Administration (FDA) officially withdrew Import Alert 66-38, "Skin Care Products Labeled as Anti-Aging Creams" (IA 66-38), potentially opening the doors for cosmetics manufacturers and marketers to make Continue Reading
FDA Continues Crackdown on Cosmetics Marketing Claims, and Microbead Ban Begins
4th Edition: Trends in Marketing Communications Law Regulating cosmetics continues to be an important priority for the Food and Drug Administration (FDA), although it remains to be seen whether the new administration will take a different approach. The FDA issued 30 warning letters to Continue Reading